MOGO PURE MORINGA OLEIFERA CAPSULES, HERBAL SUPPLEMENT, 180 QUICK RELEASE VEGGIE CAPSULE, 100% PURE, 350 MG PER CAPSU... — FDA record H-1128-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date May 24, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
MOGO PURE MORINGA OLEIFERA CAPSULES, HERBAL SUPPLEMENT, 180 QUICK RELEASE VEGGIE CAPSULE, 100% PURE, 350 MG PER CAPSULE, SUPPLEMENT FACTS MORINGA POWDER 1050 mg, Ingredients: 100% Pure Moringa Leaf Powder (Moringa Oleifera), MANUFACTURED IN USA AND Marketed by: MOGO MIRINGA LLC, PO BOX 32066 Saint Louis, MO 63132
Reason
Product may be contaminated with Salmonella Typhimurium
Classification
Class I
Recalling firm
MOGO Moringa LLC
Quantity
23,186 bottles
Agency-reported status
Ongoing
Source record identifier
H-1128-2026

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityLot codes: 15525AA exp date: 6/2027 00926AA exp date: 1/2028

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Products were sold nationwide via ecommerce (Amazon, Ebay, Etsy, and mogomiranga.com)

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jul 8, 2026
Recall initiation date
May 24, 2026
Center classification date
Jun 29, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records